This 2-part workshop is dedicated to fostering innovation and collaboration in hepatology research. In part 1, invited talks led by top experts introduce attendees to forward-thinking perspectives on essential research aspects—including cohort design, biomarker development, and clinical trials—providing a rich base for informed conversations. Part 2 deepens the discussions in breakout sessions where experts and junior faculty jointly tackle practical issues of cohort development, biomarker development, and clinical trials. This workshop promises a stimulating environment for attendees to engage in robust discussions and learn from each other with the goal of driving improvements in hepatology research and, ultimately, patient outcomes.
Constructing and Optimizing Clinical Cohorts: Unveiling the Blueprint for Exceptional Clinical Research With Lessons From the Alcoholic Hepatitis Network
Vijay H. Shah, MD, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
2:20 PM - 2:40 PM
Nov
18
2024
San Diego, CA
Decoding Portal Hypertension in Cirrhosis: Unpacking Lessons and Insights From Portal Hypertension Trials
Guadalupe Garcia-Tsao, MD, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
2:40 PM - 3:00 PM
Nov
18
2024
San Diego, CA
Trailblazing Translational Research: Unveiling, Validating, and Implementing Novel Diagnostics to Optimize Liver Transplant for Hepatocellular Carcinoma
Jorge Marrero, MD, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
3:00 PM - 3:20 PM
Nov
18
2024
San Diego, CA
Q&A
Christine C Hsu, MD, Moderator
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Objectives
Describe how to build a cohort for clinical research.
Identify how to leverage translational research or biomarkers to improve patient clinical outcomes in liver transplantation.
Review how to optimize study designs and endpoints, and overcome pitfalls in clinical trial design in portal hypertension.